HSD88 Current Epcoritamab Plus Rituximab and Lenalidomide (R2) Perceptions for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
Year: 2024
Type: conference-abstract
Source: Value in Health
Authors: E Levine, D Gentile, R Swain, R.N. Bone, L. Jennings-Zhang, Y. Jeune-Smith, B Feinberg
Institution: Cardinal Health (United States)
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4405749007